SEAAIS 2021 76th Annual Meeting
The SEAAIS 2021 meeting will provide learners with knowledge regarding novel disease state developments and the expanding therapeutic armamentarium in the field of allergy, asthma and immunology. Learners will not only gain insights with regard to selecting the best therapeutic alternative for each patient, but they will also have the opportunity to develop novel strategies designed to enhance therapeutic adherence through shared decision making.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Allied health professionals
Upon completion of this activity the participant should be able to:
- Examine biologics available for the treatment of asthma and discuss recommendations that can be made choosing a biologic for an asthma patient.
- Examine testing methods for metal allergy patients.
- Review common dermatologic conditions treated by allergists and identify improved treatment options.
- Review other uses for biologics such as treating hives and nasal polyps.
Michael Wechsler, MD
Consultant: Genentech, AstraZeneca, GSK, Novartis, Regeneron, Sanofi, Amgen, Boehringer Ingelheim
John Oppenheimer, MD
Consultant: AstraZeneca, Amgen, GSK, Sanofi
Speaker: ACCP<ACAAI, Sanofi, GSK
J. Allen Meadows, MD
Consultant: Aimmune, Teva
Speaker: Regeneron, Pfizer, AstraZeneca, Sanofi, Optinose, Teva
Advisory Board Member: Sanofi
David Khan, MD
Niraj Patel, MD
Speaker: CSL Behring, Takeda, Horizon
Advisory Board Member: Takeda, Horizon
The following have no relevant financial relationships to disclose:
Anna Nowak-Wegrzyn, MD
Jonathan Spergel, MD, PhD
Tina Hartert, MD
Stokes Peebles, MD
- 12.75 AMA PRA Category 1 Credit™
- 12.75 Attendance